Published in Am J Obstet Gynecol on October 21, 2009
Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation (2011) 2.55
Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy (2013) 2.22
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med (2013) 2.06
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation (2012) 1.88
Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. J Am Soc Nephrol (2015) 1.25
Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med (2011) 1.13
Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension (2013) 1.11
Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem (2010) 1.02
Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension (2012) 0.97
New developments in the pathogenesis of preeclampsia. Adv Chronic Kidney Dis (2013) 0.97
Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension (2012) 0.96
Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One (2012) 0.94
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria. Geburtshilfe Frauenheilkd (2013) 0.89
Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth (2014) 0.89
Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol (2015) 0.88
Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG (2013) 0.88
Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Am J Obstet Gynecol (2013) 0.87
Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med (2013) 0.87
Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia. BMC Med (2013) 0.85
Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia. PLoS One (2016) 0.84
Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments. Pharmacoeconomics (2015) 0.83
Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia. PLoS One (2013) 0.83
Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency. DNA Cell Biol (2012) 0.82
Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination. PLoS One (2014) 0.81
Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control (2016) 0.79
The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia. Iran J Reprod Med (2015) 0.79
Epigenetics and Preeclampsia: Defining Functional Epimutations in the Preeclamptic Placenta Related to the TGF-β Pathway. PLoS One (2015) 0.79
Maternal plasma soluble TRAIL is decreased in preeclampsia. J Matern Fetal Neonatal Med (2013) 0.79
Angiogenic factors in preeclampsia: potential for diagnosis and treatment. Curr Opin Nephrol Hypertens (2013) 0.79
Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study. BMC Pregnancy Childbirth (2013) 0.79
Multiple pregnancies in CKD patients: an explosive mix. Clin J Am Soc Nephrol (2012) 0.78
Molecular Mechanisms of Preeclampsia. Cold Spring Harb Perspect Med (2015) 0.78
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenat Diagn (2015) 0.78
The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia. Pregnancy Hypertens (2012) 0.77
Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis. BMC Pregnancy Childbirth (2014) 0.77
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary? Expert Rev Mol Diagn (2015) 0.77
sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK. Ultrasound Obstet Gynecol (2016) 0.77
Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLoS One (2015) 0.77
FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia. Sci Rep (2017) 0.76
Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study. Dis Markers (2015) 0.76
Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis. Int J Mol Sci (2016) 0.76
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. BMC Pregnancy Childbirth (2014) 0.76
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia. BMC Pregnancy Childbirth (2013) 0.76
Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia. Int J Mol Sci (2015) 0.75
A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Causes Control (2016) 0.75
A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome. Hypertens Pregnancy (2016) 0.75
Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013). Geburtshilfe Frauenheilkd (2015) 0.75
A Prospective Study of Placental Growth Factor Assay as a Novel Biomarker in Predicting Early-Onset Preeclampsia in High-Risk Patients. J Obstet Gynaecol India (2015) 0.75
Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. Int J Mol Sci (2015) 0.75
The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study. BMC Pregnancy Childbirth (2016) 0.75
Angiogenic factors and renal disease in pregnancy. Case Rep Obstet Gynecol (2011) 0.75
Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res (2016) 0.75
Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk. J Womens Health (Larchmt) (2016) 0.75
Second-trimester urine nephrin:creatinine ratio versus soluble fms-like tyrosine kinase-1:placental growth factor ratio for prediction of preeclampsia among asymptomatic women. Sci Rep (2016) 0.75
A cohort evaluation on arterial stiffness and hypertensive disorders in pregnancy. BMC Pregnancy Childbirth (2012) 0.75
Circulating angiogenic factors in a pregnant woman on intensive hemodialysis: a case report. Can J Kidney Health Dis (2016) 0.75
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation (2011) 3.33
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med (2016) 2.99
A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care (2004) 2.94
The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med (2008) 2.70
Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol (2007) 2.68
Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. Am J Epidemiol (2009) 2.55
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med (2013) 2.06
Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J Physiol (2009) 1.74
Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur J Heart Fail (2008) 1.64
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension (2005) 1.48
Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies. Am J Obstet Gynecol (2011) 1.43
Rate of dyspareunia after delivery in primiparae according to mode of delivery. Eur J Obstet Gynecol Reprod Biol (2005) 1.43
Predictors of overweight during childhood in offspring of parents with type 1 diabetes: Response to Hummel et al. Diabetes Care (2009) 1.41
Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy (2012) 1.39
Natriuretic peptide system in fetal heart and circulation. J Hypertens (2002) 1.38
Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online (2008) 1.25
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) (2007) 1.22
Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol (2007) 1.22
Secular trends in neonatal macrosomia in Berlin: influences of potential determinants. Paediatr Perinat Epidemiol (2003) 1.21
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension (2013) 1.20
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension (2008) 1.16
Perinatal lead and mercury exposure in Austria. Sci Total Environ (2010) 1.15
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) (2012) 1.14
Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance. Diabetes Care (2003) 1.14
Cross-fostering to diabetic rat dams affects early development of mediobasal hypothalamic nuclei regulating food intake, body weight, and metabolism. J Nutr (2004) 1.13
Uterine vascular function in a transgenic preeclampsia rat model. Hypertension (2008) 1.12
Epigenetic malprogramming of the insulin receptor promoter due to developmental overfeeding. J Perinat Med (2010) 1.10
Comparing uterine electromyography activity of antepartum patients versus term labor patients. Am J Obstet Gynecol (2005) 1.10
A great lack of knowledge regarding umbilical cord blood banking among pregnant women in Berlin, Germany. J Perinat Med (2010) 1.10
Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am J Reprod Immunol (2005) 1.08
Long-term impact of breast-feeding on body weight and glucose tolerance in children of diabetic mothers: role of the late neonatal period and early infancy. Diabetes Care (2005) 1.07
'Programming' of orexigenic and anorexigenic hypothalamic neurons in offspring of treated and untreated diabetic mother rats. Brain Res (2005) 1.07
Fetal scalp pH and ST analysis of the fetal ECG as an adjunct to CTG. A multi-center, observational study. J Perinat Med (2004) 1.06
Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy? J Perinat Med (2007) 1.06
Prevalence and risk factors for early postpartum anemia. Eur J Obstet Gynecol Reprod Biol (2010) 1.05
Chorioangioma--new insights into a well-known problem. I. Results of a clinical and morphological study of 136 cases. J Perinat Med (2003) 1.03
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond) (2012) 1.00
Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). J Perinat Med (2005) 1.00
Emergency cerclage versus bed rest for amniotic sac prolapse before 27 gestational weeks. A retrospective, comparative study of 161 women. Eur J Obstet Gynecol Reprod Biol (2008) 1.00
Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail (2007) 0.99
Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med (2006) 0.98
Fibrosis rather than blood pressure determines cardiac BNP expression in mice. Regul Pept (2003) 0.97
Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism (2009) 0.96
Umbilical cord hypercoiling and thinning: a rare cause of intrauterine death in the second trimester of pregnancy. Pediatr Dev Pathol (2006) 0.96
Risk factors for fetal-to-maternal transfusion in Rh D-negative women--results of a prospective study on 942 pregnant women. J Perinat Med (2004) 0.95
Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension (2010) 0.95
Peptide and protein profiles in serum and follicular fluid of women undergoing IVF. Hum Reprod (2006) 0.94
Iron deficiency is prevalent in a sample of pregnant women at delivery in Germany. Eur J Obstet Gynecol Reprod Biol (2002) 0.94
Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix. J Histochem Cytochem (2006) 0.94
Effect of the stage of lactation in humans on carotenoid levels in milk, blood plasma and plasma lipoprotein fractions. Eur J Nutr (2004) 0.94
Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants. Ann Nutr Metab (2008) 0.93
Risk for gestational diabetes and hypertension for women with twin pregnancy compared to singleton pregnancy. Arch Gynecol Obstet (2003) 0.93
Macrophage-derived IL-33 is a critical factor for placental growth. J Immunol (2013) 0.93
Pseudoaneurysm of the uterine artery after cesarean delivery: sonographic diagnosis and treatment. J Ultrasound Med (2002) 0.92
The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem (2012) 0.92
Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf) (2008) 0.91
Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia. J Reprod Immunol (2007) 0.91
Preconceptional factors associated with very low birthweight delivery in East and West Berlin: a case control study. BMC Public Health (2002) 0.91
The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol (2010) 0.91
Intrathoracic dislodgement of pleuro-amniotic shunt. Three case reports with long -term follow-up. Fetal Diagn Ther (2005) 0.91
Robust fetal ECG extraction and detection from abdominal leads. Physiol Meas (2014) 0.91
O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J Proteome Res (2009) 0.90
Does globalization and change demand a different kind of perinatal research? J Perinat Med (2008) 0.90
Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost (2008) 0.89
Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth (2014) 0.89
Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res (2009) 0.89
Prenatal detection of congenital heart defects: a survey on clinical practice in Spain. Fetal Diagn Ther (2010) 0.89
Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr (2010) 0.88
Serum levels of heat shock protein 70 in patients with preeclampsia: a pilot-study. Wien Klin Wochenschr (2002) 0.88
Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers. Am J Obstet Gynecol (2002) 0.88
Atosiban versus usual care for the management of preterm labor. J Perinat Med (2007) 0.88
Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia. J Matern Fetal Neonatal Med (2011) 0.88
Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis (2007) 0.87
Breast cancer diagnosed during pregnancy. Anticancer Res (2007) 0.87
Hemodynamic evaluation in pregnancy: limitations of impedance cardiography. Physiol Meas (2012) 0.87
Impact of array comparative genomic hybridization-derived information on genetic counseling demonstrated by prenatal diagnosis of the TAR (thrombocytopenia-absent-radius) syndrome-associated microdeletion 1q21.1. Am J Hum Genet (2007) 0.87
Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol (2008) 0.86
Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem (2009) 0.86
Localization of alpha-tocopherol transfer protein in trophoblast, fetal capillaries' endothelium and amnion epithelium of human term placenta. Free Radic Res (2004) 0.86
Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig (2004) 0.85
Angle of progression measurements of fetal head at term: a systematic comparison between open magnetic resonance imaging and transperineal ultrasound. Am J Obstet Gynecol (2011) 0.85
Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction. Obstet Gynecol (2014) 0.85
The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction. J Perinat Med (2014) 0.85
Excretion of vitamin A in urine of women during normal pregnancy and pregnancy complications. Ann Nutr Metab (2004) 0.85
Comparison of point-of-care-testing glucose meters with standard laboratory measurement of the 50g-glucose-challenge test (GCT) during pregnancy. Clin Biochem (2003) 0.85
N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial. Cardiovasc Diabetol (2011) 0.85
Noninvasive fetal sex determination in maternal plasma: a prospective feasibility study. Genet Med (2012) 0.84